Інформація опублікована з довідковою метою і не є рекламою, офертою, публічною пропозицією або керівництвом до застосування. Представлена виключно для інформування наших пацієнтів, які перебувають за кордоном. Сайт не здійснює жодної дистанційної торгівлі. Продаж, розповсюдження, доставка та призначення товарів через веб-ресурс не провадяться. Застосування товарів та медичних послуг можливе виключно за призначенням лікаря. Консультації надаються фахівцями клініки у очному форматі або за допомогою дистанційної медичної консультації у рамках чинного законодавства. Прошу звернути Вашу увагу, що у цьому довіднику продаж товарів програмно не передбачено.
INDICATIONS
- Treatment of major depressive disorder.
- Treatment of peripheral neuropathic pain in diabetes.
- Treatment of generalized anxiety disorder.
Ezequa is intended for use in adults.
CONTRAINDICATIONS / SIDE EFFECTS
- Hypersensitivity to the active substance or any of the excipients.
- Concurrent use with non-selective and irreversible monoamine oxidase inhibitors (MAOIs) is contraindicated.
- Liver disease with impaired function.
- Concurrent use with fluvoxamine, ciprofloxacin, or enoxacin (potent CYP1A2 inhibitors) is contraindicated due to increased plasma concentration of duloxetine.
- Severe renal impairment (creatinine clearance < 30 ml/min).
- Initiation of treatment is contraindicated in patients with uncontrolled hypertension due to the risk of hypertensive crisis.
DOSAGE
- Major depressive disorder: The recommended initial and maintenance dose is 60 mg once daily, regardless of meals.
- Generalized anxiety disorder: Initial dose is 30 mg once daily, with a possible increase to 60 mg depending on patient response.
- Peripheral neuropathic pain in diabetes: Initial and maintenance dose is 60 mg daily.
SPECIAL INSTRUCTIONS
- Elderly patients: No dose adjustment is required based on age, but caution is advised.
- Patients with liver impairment: Use is contraindicated.
- Patients with renal impairment: No dose adjustment is required for mild to moderate renal impairment.
METHOD OF ADMINISTRATION
For oral use.
The package contains 28 capsules.
- Treatment of major depressive disorder.
- Treatment of peripheral neuropathic pain in diabetes.
- Treatment of generalized anxiety disorder.
Ezequa is intended for use in adults.
CONTRAINDICATIONS / SIDE EFFECTS
- Hypersensitivity to the active substance or any of the excipients.
- Concurrent use with non-selective and irreversible monoamine oxidase inhibitors (MAOIs) is contraindicated.
- Liver disease with impaired function.
- Concurrent use with fluvoxamine, ciprofloxacin, or enoxacin (potent CYP1A2 inhibitors) is contraindicated due to increased plasma concentration of duloxetine.
- Severe renal impairment (creatinine clearance < 30 ml/min).
- Initiation of treatment is contraindicated in patients with uncontrolled hypertension due to the risk of hypertensive crisis.
DOSAGE
- Major depressive disorder: The recommended initial and maintenance dose is 60 mg once daily, regardless of meals.
- Generalized anxiety disorder: Initial dose is 30 mg once daily, with a possible increase to 60 mg depending on patient response.
- Peripheral neuropathic pain in diabetes: Initial and maintenance dose is 60 mg daily.
SPECIAL INSTRUCTIONS
- Elderly patients: No dose adjustment is required based on age, but caution is advised.
- Patients with liver impairment: Use is contraindicated.
- Patients with renal impairment: No dose adjustment is required for mild to moderate renal impairment.
METHOD OF ADMINISTRATION
For oral use.
The package contains 28 capsules.
